Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features

Journal of Neurology, Neurosurgery, and Psychiatry
Juliette SvahnFrancophone anti-MAG cohort Group

Abstract

To assess the clinicopathological and therapeutic features of patients with low (≥1000 to <10 000 Bühlmann Titre Units) (BTU), medium (10 000-70 000) or high (≥70 000) anti-myelin-associated glycoprotein (anti-MAG) antibody titres. We retrospectively and prospectively analysed standardised report forms and medical records of 202 patients from 14 neuromuscular centres. Mean age at onset and mean time between symptom onset to last follow-up were respectively 62.6 years (25-91.4) and 8.4 years (0.3-33.3). Anti-MAG antibody titres at diagnosis were low, medium or high in 11%, 51% and 38% of patients. Patients presented with monoclonal gammopathy of undetermined significance in 68% of cases. About 17% of patients presented with 'atypical' clinical phenotype independently of anti-MAG titres, including acute or chronic sensorimotor polyradiculoneuropathies (12.4%), and asymmetric or multifocal neuropathy (3%). At the most severe disease stage, 22.4% of patients were significantly disabled. Seventy-eight per cent of patients received immunotherapies. Transient clinical worsening was observed in 12% of patients treated with rituximab (11/92). Stabilisation after rituximab treatment during the 7-12-month follow-up period was observed in ...Continue Reading

References

Nov 1, 1988·Stroke; a Journal of Cerebral Circulation·R F Bloch
May 1, 1988·Stroke; a Journal of Cerebral Circulation·J C van SwietenJ van Gijn
Mar 18, 2003·Journal of Neurology, Neurosurgery, and Psychiatry·A PestronkT D Levine
Jun 30, 2005·Muscle & Nerve·Laura Broglio, Giuseppe Lauria
Mar 15, 2006·Neurology·S RenaudA J Steck
Apr 1, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·R C Graham, R A C Hughes
Sep 14, 2006·Current Opinion in Neurology·Andreas J SteckSusanne Renaud
Jun 15, 2007·Journal of the Peripheral Nervous System : JPNS·Luana BenedettiAngelo Schenone
Nov 19, 2008·Neurology·L BenedettiA Schenone
Dec 17, 2008·Annales de pathologie·Jean-Michel VallatLaurent Magy
May 15, 2013·Neurology·Jean-Marc LégerUNKNOWN RIMAG Study Group (France and Switzerland)
Sep 17, 2013·Muscle & Nerve·Hessel Franssen, Dirk C G Straver
Dec 11, 2013·Haematologica·Marie-Anne HospitalVéronique Leblond
Aug 15, 2014·Journal of the Neurological Sciences·Emilie SalaJean-Christophe Antoine
Jun 13, 2015·Journal of Immunology Research·Laurent MagyJean-Michel Vallat
Jan 11, 2016·Journal of the Peripheral Nervous System : JPNS·Ruxandra Iancu FerfogliaJean-Marc Léger
Jun 9, 2016·Expert Review of Neurotherapeutics·Jean-Michel VallatStéphane Mathis
Jun 18, 2016·Journal of Neurology·Pierre LozeronNathalie Kubis
Jan 31, 2017·Journal of the Neurological Sciences·Pietro E DonedduRobert D M Hadden
May 10, 2017·Journal of the Neurological Sciences·Sébastien GazzolaShahram Attarian
May 10, 2017·Journal of the Neurological Sciences·Marinos C Dalakas
May 16, 2017·Journal of Neurology, Neurosurgery, and Psychiatry·Marta CampagnoloChiara Briani

❮ Previous
Next ❯

Citations

May 10, 2019·BMJ : British Medical Journal·Kelly Graham Gwathmey, Kathleen T Pearson
Jul 18, 2019·Current Opinion in Neurology·Michael P Lunn
Jun 28, 2018·Journal of Neurology, Neurosurgery, and Psychiatry·Nidhi GargMatthew C Kiernan
May 14, 2020·Brain Sciences·Marilisa BoscarinoGiovanni Assenza
Dec 1, 2018·Journal of Neurology·Rachel Brown, Lionel Ginsberg
May 13, 2019·Acta neurologica Belgica·Giuliana GalassiMarcella Malagoli
May 16, 2019·Journal of Neurology·Emilien DelmontJose Boucraut
Oct 13, 2018·Nature Reviews. Disease Primers·Bernd C KieseierHans-Peter Hartung
Feb 8, 2020·Der Internist·W N Löscher, B Iglseder
Dec 17, 2019·Journal of Neuroimmunology·Taro MatsuiSusumu Kusunoki
Feb 24, 2021·Journal of the Peripheral Nervous System : JPNS·Pietro E DonedduUNKNOWN Italian Peripheral Nervous System Association (ASNP)
Mar 2, 2021·Journal of the Neurological Sciences·Sabrina MatàSandro Sorbi
Apr 2, 2021·Frontiers in Neurology·Deepak MenonVera Bril
Apr 17, 2021·Clinics in Geriatric Medicine·Yaowaree Leavell, Susan C Shin
Aug 30, 2021·Journal of the Neurological Sciences·Nathalie DeschampsJean-Michel Vallat
Sep 17, 2021·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Haruki Koike, Masahisa Katsuno
Nov 4, 2021·Neurology. Neuroimmunology and Neuroinflammation·Lorena Martín-AguilarLuis Querol

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.